NCT00098943View on ClinicalTrials.gov

NGR-TNF in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 30, 2007

Conditions
Colorectal CancerHead and Neck CancerKidney CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

CNGRC peptide-TNF alpha conjugate

Trial Locations (2)

D-20246

University Medical Center Hamburg - Eppendorf, Hamburg

NL-6500 HB

Universitair Medisch Centrum St. Radboud - Nijmegen, Nijmegen

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00098943 - NGR-TNF in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter